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Abstract
Background: Abrasion arthroplasty (AAP) is a procedure by which intrinsic cartilage healing is believed to be stimulated.
Although clinically accepted for degenerative and traumatic cartilage lesions scientific evidence at a molecular level that
proves the effect of AAP is scarce.
Method: Mononuclear cells were extracted from postoperative joint effusions 21.5 h post AAP and simple debridement
of cartilage lesions. Luminex, ELISA and FACS experiments were performed. Immunohistochemical stainings of cell
cultures for cartilage markers were used to confirm the findings.
Results: Postoperative joint effusions after AAP showed increased contents of Mononuclear cells compared to
Arthroscopic Chondroplasty (ACP). BMP-4 and IGF were increased in AAP as complared to ACP. Mononuclear cells
isolated after AAP express the MSC markers CD 73, CD 105, CD 90, CD 44 and are CD34 negative. Chondrogenic
differentiation was demonstrated by positive staining for Sox9, collagen II, proteoglycan, chondroitin-4-sulfate.
Conclusion: Our results support the clinical application of AAP as a procedure that enhances cartilage repair as
an alternative to far more complex procedures that have gained popularity. Furthermore the data presented
supports clinical investigations that recommend not to use suction drainage as by this procedure a considerable
amount of the regeneratory potential of postoperative joint effusions might be extracted.
Background
Cartilage defects lack intrinsic healing potential and
therefore cause an enormous number of orthopedic inter-
ventions [1]. So-called “marrow stimulating techniques” i.e.
abrasion arthroplasty and microfracturing are common
practice but the clinical outcome varies considerably [2, 3].
Alternative modern methods i.e. autologous chondrocyte
transplantation, stem cell augmented repair techniques
and osteochondral transfer have gained popularity and
seem to provide a fair clinical outcome but such proce-
dures are technically demanding and require a highly
specialized infrastructure. Finally all procedures requiring
ex-vivo cell culture are time consuming, involve repeated
surgical intervention and are costly.
Therefore, many surgeons still advocate abrasion arthro-
plasty (AAP) as a first-line treatment for cartilage defects
of the knee joint as it is easy to perform and may be com-
bined with other interventions like repair of meniscal
lesions or correction of the limb axis. Nevertheless, the
general notion seems that AAP is palliative, predomin-
antly used for patients seeking an alternative to total knee
replacement [4].
Based on follow-up studies using magnetic resonance
imaging (MRI) and animal experiments, it is well ac-
cepted that debridement of osteoarthritic lesions via
arthroscopy does lead to fibrous tissue formation at the
site of the defect but the regenerative cartilage substitute
is of inferior quality and prone to degenerate over time
[5–7]. Several scientific reports have highlighted the im-
portance of stem cells from synovium, periosteum or bone
marrow for the regeneration of cartilage and therefore
many modern techniques involve transfer of autologous
mesenchymal stem cells (MSC) or periosteal cells into the
defect [8–10]. MSC have particularly raised interest as
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they seem to adhere to cartilage lesions [11]. Despite the
increasing evidence that the local delivery of MSC is of
major importance for cartilage repair, there are no clinical
studies that clarify whether relatively simple and com-
monly used surgical procedures like AAP are cause for the
release of MSC into the joint cavity. We have therefore
investigated into the cellular composition of postoperative
joint effusion after AAP with regard to its MSC content.
Methods
The study was approved by the institutional review board
of the University Hospital Schleswig-Holstein Campus
Kiel (Ethik-Kommission der Medizinischen Fakultät der
Christian-Albrechts-Universität zu Kiel). Written in-
formed consent was obtained from all patients.
Study design
We studied 2 cohorts of adult caucasian patients who had
only one joint affected by osteoathritis. Patients enrolled in
this study underwent abrasion arthroplasty (AAP) n = 6–37
or abrasion chondroplasty (ACP) n = 6–21. The indication
was assessed by MRT. The outerbridge score were assessed
athroscopicly and documented by photographs at the
beginning of the operation. The mean age of the patients
who underwent AAP was 54.9 ± 12.1 years with an outer-
bridge score between I and III. The mean age of the pa-
tients of the ACP group was 41.6 years ±16.5 with an
outerbrige score between III-IV.
Cell isolation from joint effusions
The joint effusions were collected for 21 h ± 2.5 h post-
operation. Patient consent was obtained according to the
requirements of the University Hospital Schleswig-
Holstein Campus Kiel. Undiluted joint effusion was used
to isolate mononuclear cells by ficoll density gradient
centrifugation (1.100 g/ml, Biochchrom AG, Berlin). The
cells were cultured in DMEM high Glucose, 10 % FCS,
1 % Penincilin-Streptomicin, 0.1 mM MEM non essen-
tial amino acids, 1 % HEPES-buffer (Gibcco, Germany)
in tissue flasks with standard surface for adherent cells
(Sarstedt, Nümbrecht, Germany) at 37 °C and 5 % CO2.
Non-adherent cells were removed by changing the
medium after 3 days. The cells were expanded up to
21 days for further analysis.
Cell counting
Cells were stained by trypan blue and living cells were
counted with a Neubauer chamber.
High-density culture
Only cells isolated after AAP could be extended in a suf-
ficient manor to cultivate in high-density cultre. There-
for 300,000 cells where centrifuged at 250 g for 10 min
in a 15-ml-polypropylene tube and further cultivated for
3 weeks at 37 °C and 5 % CO2 in the previously men-
tioned culture medium on a total volume of 10 ml. The
Medium was changed every 2–3 days.
Immunohistochemistry
For immunohistochemical analysis the cell pellets were
fixed in 4 % neutrally bufferd formalin for 2 h and
embedded in paraffin at 56 °C. Imunohistochemical
stainings were performed on serial sections of 5 μm
thickness with antibodies against Sox9 (pretreatment:
heat retrieval 30 min in 11 mM citronic acid, pH 6, dilu-
tion 1:500; BS1597, Bioworld, USA), chondrogen matrix
proteins: collagen type II (pretreatment: proteinase K
(10 ug/ml) for 10 min, dilution 1:50; BT21-5000-60, bio-
trend, Germany), proteoglycan (pretreatment: Incuba-
tion in reduction-solution for 2 h at 37 °C (50 mM Tris,
200 mM NaCl, 10 mM DTT pH7.35) followed by incu-
bation for 1 h at 37 °C in alcylation solution (40 mM
iodoacetamide in PBS), dilution 1:20; 12/12/1-C-6,
DSHB, USA) and chondroitin-4-sulfate (pretreatment: heat
retrivial in 11 mM citronic acid, pH6 for 20 min, dilu-
tion1:200; MAB2030, Chemicon international, Germany).
Binding of species-specific biotinylated secondary anti-
bodies was visualized with AEC-substrate chromogen
(AEC-Kit) (00-2007, Invitrogen, Germany). Sections were
counterstained with hematoxylin.
Luminex-assay/ELISA
Serum from postoperative joint effusions was prepared
from postoperative joint effusions by centrifuging at
1760 g for 10 min. The supernatant was stored at −20 °C
until analysis. IGF-1 analysis was performed by Luminex-
assay (Millipore, Germany). BMP4, BMP7 and TGFβ con-
tents were measured by ELISA (R&D-Systems, Germany).
Analyses were performed of serum according to the
manufacturer protocols.
Flow cytometry
After a 21 day expansion period of mononuclear cells
isolated from joint effusions the expression of CD34
(120-000-803, Miltenyi Biotec, Germany), CD44, (H4C4,
DSHB, USA), CD73 (12-0739, eBioscience, USA), CD90
(555593, BD Pharmingen, USA) and CD105 (555690, BD
Pharmingen, USA) was examined using flow cytometry.
250 000 cells per antibody staining were used. Cells were
washed in PBS before being recovered from cultures and
resuspended in FACS-buffer consisting of 1 % BSA in
PBS. Cells were stained for 30 min at 4 °C using primary
antibodies 1:100 diluted in FACS-buffer. Subsequently
cells were washed twice with FACS-buffer prior to the
incubation with 1:200 diluted secondary antibody FITC
goal anti-mouse IgG/IgM (555988, BD Pharmingen, USA)
at 4 °C for 30 min. After staining the cells were washed
twice and analyzed using FACS Canto™ II flow cytometer
Beckmann et al. BMC Musculoskeletal Disorders  (2015) 16:250 Page 2 of 7
running on FACSDiva software (Becton Dickinson, USA).
Data were evaluated using FlowJo Software (Tree Star
Inc., USA). Appropriate controls were included for the
analysis.
Statistical analysis
Statistical analysis were performed with Kruskal-Wallis-
Test followed by Dunns post hoc testing and student’s
t-test. Group differences were considered significant if
p <0.05 (*), p ≤0.005 (**), p ≤0.001 (***).
Results
First we assessed the contents of mononuclear cells in
postoperative joint effusions 21 h ± 2.5 h post opera-
tively. Effusions from patients undergoing AAP had a
higher number of mononuclear cells than controls from
chondroplasty alone (mean ± SEM: 111,923 ± 33,038 for
AAP:, 32,500 ± 7460 for ACP; n ≤ 7, p < 0.0504) (Fig. 1).
In addition, the growth factor content of the cell-free
fraction of joint effusions was analyzed by ELISA/Luminex
to clarify whether the AAP provides a chondrogenic envir-
onment to promote cartilage healing (Fig. 2). The analysis
of AAP and ACP revealed significantly higher concentra-
tions of Insulin-like growth factor (IGF) (P value: <0.0001
AAP: 2902 ± 682 pg/ml, p value vs serum: ≤ 0.001, ACP:
2486 ± 759 pg/ml, p value vs serum: ≤ 0.001 Serum: 237 ±
40 pg/ml) and Transforming growth factor beta (TGF-β)
(P value: <0.0001 AAP: 21,353 ± 1471 pg/ml p value vs
serum: ≤ 0.001, ACP: 19,541 ± 1941 pg/ml, p value vs
serum: ≤ 0.005 Serum: 7254 ± 1593 pg/ml) as compared to
serum levels. Bone morphogenic protein 4 and BMP 7
were detectable in ACP and AAP but the BMP4 level was
much higher than BMP 7 level (BMP-4 and BMP-7)
(BMP-4: AAP: 474 ± 28 pg/ml, ACP: 425 ± 49 pg/ml;
BMP-7: AAP: 66 ± 5.9 pg/ml, ACP: 77 ± 16 pg/ml).
Fig. 1 Mononuclear cells released after AAP and ACP. Postoperative
joint effusion was collected for 21 h ± 2.5 h and mononuclear cells were
isolated by ficoll density gradient centrifugation. Cells were counted
after 1 week (n≥ 8; mean, SEM)
Fig. 2 Chondrogenic growth factors TGF-β, IGF-1, BMP-4 and BMP7 in postoperative joint effusion released after AAP and ACP (Kruskal-Wallis-Test
* p ≤ 0.05, ** p≤ 0.005, *** p≤ 0.001, n ≥ 6; mean, SEM)
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Although there were no significant differences between
AAP and ACP, there was a trend towards higher concen-
trations after AAP in BMP 4 level.
In order to characterize the phenotype of the cells
released after AAP and ACP a flow cytometry analysis
was performed. Bone marrow (BM) derived-MSCs were
analyzed within passages 3 to 6 for comparison. Remark-
ably, AAP-released cells show a CD73+, CD105+, CD90+,
CD44+, CD34− expression pattern (Fig. 3) coinciding
with the typical MSC pattern defined by the criteria of
the International Society for Cellular Therapy [12].
ACP -released cells could not be expanded to a suffi-
cient number for flow cytometry analysis.
Finally immunohistochemical stainings were performed
on isolated cells of postoperative joint effusions growing
in high density cultures (Fig. 4). After 21 days of culture,
the cells showed strong positive staining for Sox9, Col II,
proteoglycan and chondroitin-4-sulfate indicating the
chondrogenic differentiation.
Discussion
In this study we provide evidence for a biological mech-
anism that can in part explain the effectiveness of the
common AAP procedure. We hypothesized that our
findings have long been assumed by orthopedic surgeons
who regularly indicate AAP as a treatment option with-
out a clear scientific explanation.
Postoperative joint effusions as such have repeatedly
given rise to extensive discussion about whether or not
to use suction drainage [13]. Although many arthro-
scopic surgeons favour the use of wound suction drains,
clear clinical evidence of their effectiveness is still
missing. A limited number of studies do indicate that
the effect of hemarthosis is greater during the first
Fig. 3 Mononuclear cells isolated after AAP express the MSC markers CD 73, CD 105, CD 90, CD 44 and are CD34 negative (MSCs n = 4,
AAP n = 6)
Beckmann et al. BMC Musculoskeletal Disorders  (2015) 16:250 Page 4 of 7
post-operational weeks if no intra-articular drain is
inserted, but no differences in clinical outcome in
terms of pain, infections and range of motion could
be detected in short- and long-term follow-ups [13,
14]. We could detect a significant increase in the
chondrogenic growthfactors TGFβ and IGF compared
to serum level. Also the BMP4 levels is increased
compared to normal serum level in literature (BMP4
serum level: 17.8 ± 35.2) [15] while the serum level of
the osteogenic growth factor BMP7 is at the same
level after AAP and ACP compared to serum level in
literature (BMP7 serum level: 27 ± 82.2 pg/ml) [15].
Our study reveals the presence of a powerful mixture
of MSC and chondrogenic growth factors in joint effu-
sions. It appears thus questionable whether or not wound
drainage is beneficial after arthroscopic procedures or
even counterproductive, as a considerable amount of re-
generative potential may be drained out of the joint. Our
results do rather imply not to use postoperative drainage
in order to preserve the healing potential of hemarthrosis
and joint effusion after AAP.
Clearly, postoperative joint effusions consist of rem-
nants of irrigation fluid and hemarthrosis as well as any
tissue not irrigated. We here compared the content of
mononuclear cells in effusions after AAP and ACP dem-
onstrating that despite some dilution by irrigation fluid
the cellular content is by far higher after the marrow-
stimulating procedure.
Our findings are supported by the molecular analysis
of surface proteins that clearly identify cells preserved
from postoperative effusions, especially MSC. Flow cy-
tometry is well recognized as a standard detection
method to identify cellular fractions within a sample.
Cells presenting a CD73+, CD 90+, CD44+, CD 105+,
CD34− immunphenotype have shown typical properties
of MSC as they can be used for culture initiation and
are able to form secondary colonies [12, 16]. Cells exhi-
biting such properties even after a 21 days culture of pri-
mary cells from joint effusions may be the actor of a
powerful repair mechanism that can be initiated by
AAP.
The cells released after AAP provide a chondrogenic
phenotype in 3D cultivation. We were able to detect the
classical chondrogenic differentiation marker Sox9, Col
II, proteoglycan and chondroitin-4-sulfate by immuno-
staining. Unfortunately there was no possibility to perform
high density culturing of ACP gained cells. The number of
ACP gained cells was to low after 3 weeks expansion. A
further increase of the expansion phase would lead to an
aging process of the mononuclear cells which make a
direct comparison between AAC and AAP difficult.
Chondrogenic differentiation capacity has long been
reported for MSC and subsequently Sox9 was identified
to be a master regulator of chondrogenic differentiation
[17–19]. Therefore in order to improve cartilage repair
modern concepts involve autologous MSC delivery into
chondral defects [20]. Recent reports on intra-articular
injection of MSC do imply that MSC within a joint effu-
sion can integrate into cartilage lesions. Hence one
proof-of-concept study demonstrates clinical improve-
ment of patients suffering from painful osteoarthritis of
the knee [10].
Chondrogenic differentiation is promoted by specific
growth factors and cytokines of which we analyzed IGF-1
and TGF-β (for a review see [21]). BMP-4 and BMP-7
contents were also measured in the cell-free fraction of
the joint effusions as they play a pivotal role in MSC-
derived chondrogenesis [22, 23]. Notably, there were no
Fig. 4 Chondrogenic differentiation of mononuclear cells isolated after AAP. High density culture after 21 days were stained against
chondrogenic markers: Sox9, collagen II, proteoglycan, chondroitin-4-sulfate. Second lane shows no-primary controls. Bar represents 100 μm
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significant differences between chondroplasty alone and
AAP, whereas the levels of IGF-1, TGF-β and BMP-4 were
markedly higher than serum levels. Possibly the release of
these growth factors is triggered by the surgical interven-
tion itself. These factors are able to act synergistically with
a high number of other regenerative cells.
Abrasion arthroplasty is used for cartilage lesions of any
grade. Typically Outerbridge grade II-IV lesions do become
clinically symptomatic and lead surgeons to therapeutic ac-
tion [7, 24]. Here, we are concentrating on AAP because it
is easy to perform especially if cartilage lesions are seen
during a diagnostic procedure. For most other marrow-
stimulating procedures, special drills have to be used
whereas AAP can be performed with a shaver. The
Procedure involves debridement of all loose chondral
tissue, scar tissue and subchondral bone to achieve
access to cancellous bone. As such microfracture might
yield comparable results [1, 3, 25].
Our study has some inherent limitations. Depending
on the grade of osteoarthritic leasions the surgeon has
choosen the operation technique in order to preserve
healthy cartilage as much as possible. This led to an im-
balance between the two investigated collectives. An
aged matched analysis would further strengthen our
conclusions.
Also the number of MSCs in the synovial fluid de-
creases with progressing osteoarthritic we were able to
detect MSCs like cells in joint effusions after AAP also
the average age of the patients were higher with a higher
outerbrige score [8].
Conclusion
In summary, we are providing novel scientific evidence
for the biological effectivity of a marrow-stimulating
arthroscopic procedure. This report supports the clinical
application of AAP and furthermore provides some argu-
ments against the use of postoperative suction drainage.
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